Literature DB >> 30028556

Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases.

Margaux Saint-Martin1, Bastien Joubert1,2, Véronique Pellier-Monnin1, Olivier Pascual1, Nelly Noraz1, Jérôme Honnorat1,2.   

Abstract

Contactin-associated protein-like 2 (CASPR2) is a cell adhesion protein of the neurexin family. Proteins of this family have been shown to play a role in the development of the nervous system, in synaptic functions, and in neurological diseases. Over recent years, CASPR2 function has gained an increasing interest as demonstrated by the growing number of publications. Here, we gather published data to comprehensively review CASPR2 functions within the nervous system in relation to CASPR2-related diseases in humans. On the one hand, studies on Cntnap2 (coding for CASPR2) knockout mice revealed its role during development, especially, in setting-up the inhibitory network. Consistent with this result, mutations in the CNTNAP2 gene coding for CASPR2 in human have been identified in neurodevelopmental disorders such as autism, intellectual disability, and epilepsy. On the other hand, CASPR2 was shown to play a role beyond development, in the localization of voltage-gated potassium channel (VGKC) complex that is composed of TAG-1, Kv1.1, and Kv1.2. This complex was found in several subcellular compartments essential for action potential propagation: the node of Ranvier, the axon initial segment, and the synapse. In line with a role of CASPR2 in the mature nervous system, neurological autoimmune diseases have been described in patients without neurodevelopmental disorders but with antibodies directed against CASPR2. These autoimmune diseases were of two types: central with memory disorders and temporal lobe seizures, or peripheral with muscular hyperactivity. Overall, we review the up-to-date knowledge on CASPR2 function and pinpoint confused or lacking information that will need further investigation.
© 2018 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990CNTNAP2zzm321990; Kv1; TAG-1; autoimmunity; neurodevelopment

Mesh:

Substances:

Year:  2018        PMID: 30028556     DOI: 10.1111/ejn.14081

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  18 in total

1.  Maternal autoantibody profiles as biomarkers for ASD and ASD with co-occurring intellectual disability.

Authors:  Alexandra Ramirez-Celis; Lisa A Croen; Cathleen K Yoshida; Stacey E Alexeeff; Joseph Schauer; Robert H Yolken; Paul Ashwood; Judy Van de Water
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 15.992

2.  Translational profiling of mouse dopaminoceptive neurons reveals region-specific gene expression, exon usage, and striatal prostaglandin E2 modulatory effects.

Authors:  Enrica Montalban; Albert Giralt; Lieng Taing; Evelien H S Schut; Laura F Supiot; Laia Castell; Yuki Nakamura; Benoit de Pins; Assunta Pelosi; Laurence Goutebroze; Pola Tuduri; Wei Wang; Katrina Daila Neiburga; Letizia Vestito; Julien Castel; Serge Luquet; Angus C Nairn; Denis Hervé; Nathaniel Heintz; Claire Martin; Paul Greengard; Emmanuel Valjent; Frank J Meye; Nicolas Gambardella; Jean-Pierre Roussarie; Jean-Antoine Girault
Journal:  Mol Psychiatry       Date:  2022-02-18       Impact factor: 13.437

3.  Anti-contactin-associated protein-like 2 antibody autoimmune encephalitis with rapidly progressive parkinsonism: a case report and literature review.

Authors:  Xiaohong Qin; Jieying Li; Yuanyuan Luo; Yunsen He; Xiaoqiang Xiao; Arui Tan; Jun Xiao
Journal:  Acta Neurol Belg       Date:  2022-10-23       Impact factor: 2.471

Review 4.  Using Zebrafish to Model Autism Spectrum Disorder: A Comparison of ASD Risk Genes Between Zebrafish and Their Mammalian Counterparts.

Authors:  Victoria Rea; Terence J Van Raay
Journal:  Front Mol Neurosci       Date:  2020-11-11       Impact factor: 5.639

Review 5.  The Polygenic Nature and Complex Genetic Architecture of Specific Learning Disorder.

Authors:  Marianthi Georgitsi; Iasonas Dermitzakis; Evgenia Soumelidou; Eleni Bonti
Journal:  Brain Sci       Date:  2021-05-14

Review 6.  Antigenic Targets of Patient and Maternal Autoantibodies in Autism Spectrum Disorder.

Authors:  Rut Mazón-Cabrera; Patrick Vandormael; Veerle Somers
Journal:  Front Immunol       Date:  2019-07-19       Impact factor: 7.561

7.  Possible coexistence of MOG-IgG-associated disease and anti-Caspr2 antibody-associated autoimmune encephalitis: a first case report.

Authors:  Pei Liu; Miao Bai; Xu Yan; Kaixi Ren; Jiaqi Ding; Daidi Zhao; Hongzeng Li; Yaping Yan; Jun Guo
Journal:  Ther Adv Neurol Disord       Date:  2020-10-29       Impact factor: 6.570

8.  Caspr2 interacts with type 1 inositol 1,4,5-trisphosphate receptor in the developing cerebellum and regulates Purkinje cell morphology.

Authors:  Liam Argent; Friederike Winter; Imogen Prickett; Maria Carrasquero-Ordaz; Abby L Olsen; Holger Kramer; Eric Lancaster; Esther B E Becker
Journal:  J Biol Chem       Date:  2020-07-16       Impact factor: 5.157

Review 9.  Cognitive impact of neuronal antibodies: encephalitis and beyond.

Authors:  L L Gibson; A McKeever; E Coutinho; C Finke; T A Pollak
Journal:  Transl Psychiatry       Date:  2020-09-01       Impact factor: 6.222

10.  Clinical Profile and Treatment Response in Patients with CASPR2 Antibody-Associated Neurological Disease.

Authors:  Sumanth Shivaram; Madhu Nagappa; Doniparthi V Seshagiri; Anita Mahadevan; Yashwanth Gangadhar; T N Sathyaprabha; Vijay Kumavat; Rose D Bharath; Sanjib Sinha; Arun B Taly
Journal:  Ann Indian Acad Neurol       Date:  2021-03-31       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.